Literature DB >> 7771647

Ethanol elevates fetal serum glutamate levels in the rat.

P I Karl1, R Kwun, A Slonim, S E Fisher.   

Abstract

Glutamate is an important excitatory neurotransmitter. However, a sustained elevation of glutamate in the extracellular space may be toxic to neurons. Because the blood-brain barrier is incomplete in the developing fetus, an elevation of fetal serum glutamate could expose the immature, growing brain to potentially toxic levels of extracellular glutamate. Chronic ethanol consumption during pregnancy is associated with an increased risk for a complex array of congenital anomalies, including alterations in the CNS, a hallmark of the fetal alcohol syndrome. Some central nervous system changes appear to involve the glutamate receptor, including reduced number and altered function. One mechanism for receptor downregulation may be a sustained elevation in extracellular glutamate. We hypothesize that chronic ethanol exposure during pregnancy leads to an elevation in fetal serum glutamate. When rats were fed ethanol-containing liquid diet throughout pregnancy, growth retardation of fetuses was observed at sacrifice (gestation day 20). Within each group, ethanol-fed, pair-fed, and ad libitum chow-fed, serum glutamate levels were generally higher in the fetus than in the dam. Ethanol treatment had no effect on fetal or maternal serum glutamine, a reciprocal metabolite of glutamate. In contrast, ethanol treatment increased serum glutamate levels in the fetal serum by nearly 50%, compared with either of the control groups. Maternal serum glutamate was not affected. The finding of ethanol-induced elevation of fetal serum glutamate suggests that the developing brain might be concurrently exposed to elevated levels of extracellular glutamate. Chronic exposure to elevated glutamate during critical periods of brain development may contribute to the pathogenesis of the fetal alcohol syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771647     DOI: 10.1111/j.1530-0277.1995.tb01488.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

1.  Acute oligodendrocyte loss with persistent white matter injury in a third trimester equivalent mouse model of fetal alcohol spectrum disorder.

Authors:  Jessie Newville; Carlos Fernando Valenzuela; Lu Li; Lauren L Jantzie; Lee Anna Cunningham
Journal:  Glia       Date:  2017-05-18       Impact factor: 7.452

2.  Long-term effects of neonatal alcohol exposure on photic reentrainment and phase-shifting responses of the activity rhythm in adult rats.

Authors:  Gregg C Allen; Yuhua Z Farnell; Ji-ung Maeng; James R West; Wei-Jung A Chen; David J Earnest
Journal:  Alcohol       Date:  2005-10       Impact factor: 2.405

3.  Fetal alcohol syndrome, chemo-biology and OMICS: ethanol effects on vitamin metabolism during neurodevelopment as measured by systems biology analysis.

Authors:  Bruno César Feltes; Joice de Faria Poloni; Itamar José Guimarães Nunes; Diego Bonatto
Journal:  OMICS       Date:  2014-05-09

4.  Developmental alcohol exposure alters light-induced phase shifts of the circadian activity rhythm in rats.

Authors:  Yuhua Z Farnell; James R West; Wei-Jung A Chen; Gregg C Allen; David J Earnest
Journal:  Alcohol Clin Exp Res       Date:  2004-07       Impact factor: 3.455

5.  Acute alcohol exposure, acidemia or glutamine administration impacts amino acid homeostasis in ovine maternal and fetal plasma.

Authors:  Shannon E Washburn; Onkar B Sawant; Emilie R Lunde; Guoyao Wu; Timothy A Cudd
Journal:  Amino Acids       Date:  2013-01-12       Impact factor: 3.520

6.  Chronic binge ethanol-mediated acidemia reduces availability of glutamine and related amino acids in maternal plasma of pregnant sheep.

Authors:  Jayanth Ramadoss; Guoyao Wu; Timothy A Cudd
Journal:  Alcohol       Date:  2008-12       Impact factor: 2.405

Review 7.  Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain.

Authors:  Catherine Lebel; Florence Roussotte; Elizabeth R Sowell
Journal:  Neuropsychol Rev       Date:  2011-03-03       Impact factor: 7.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.